Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Gp120-alum boosting of a Gag-Pol-Env DNA/MVA AIDS vaccine: poorer control of a pathogenic viral challenge.
AIDS Res Hum Retroviruses. 2003 Oct;19(10):891-900. doi: 10.1089/088922203322493067.
AIDS Res Hum Retroviruses. 2003.
PMID: 14585221
Comparative immunogenicity in rhesus monkeys of multi-protein HIV-1 (CRF02_AG) DNA/MVA vaccines expressing mature and immature VLPs.
Ellenberger D, Wyatt L, Li B, Buge S, Lanier N, Rodriguez IV, Sariol CA, Martinez M, Monsour M, Vogt J, Smith J, Otten R, Montefiori D, Kraiselburd E, Moss B, Robinson H, McNicholl J, Butera S.
Ellenberger D, et al.
Virology. 2005 Sep 15;340(1):21-32. doi: 10.1016/j.virol.2005.06.014.
Virology. 2005.
PMID: 16023165
Free article.
Item in Clipboard
An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge.
Buge SL, Richardson E, Alipanah S, Markham P, Cheng S, Kalyan N, Miller CJ, Lubeck M, Udem S, Eldridge J, Robert-Guroff M.
Buge SL, et al.
J Virol. 1997 Nov;71(11):8531-41. doi: 10.1128/JVI.71.11.8531-8541.1997.
J Virol. 1997.
PMID: 9343211
Free PMC article.
Item in Clipboard
Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251.
Buge SL, Murty L, Arora K, Kalyanaraman VS, Markham PD, Richardson ES, Aldrich K, Patterson LJ, Miller CJ, Cheng SM, Robert-Guroff M.
Buge SL, et al.
J Virol. 1999 Sep;73(9):7430-40. doi: 10.1128/JVI.73.9.7430-7440.1999.
J Virol. 1999.
PMID: 10438833
Free PMC article.
Item in Clipboard
Resistance of human immunodeficiency virus type 1 to neutralization by natural antisera occurs through single amino acid substitutions that cause changes in antibody binding at multiple sites.
Watkins BA, Buge S, Aldrich K, Davis AE, Robinson J, Reitz MS Jr, Robert-Guroff M.
Watkins BA, et al.
J Virol. 1996 Dec;70(12):8431-7. doi: 10.1128/JVI.70.12.8431-8437.1996.
J Virol. 1996.
PMID: 8970964
Free PMC article.
Item in Clipboard
Cite
Cite